William Conkling - 28 Nov 2023 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role: Director
Signature: /s/ William Conkling
Issuer symbol: CYTH
Transactions as of: 28 Nov 2023
Net transactions value: $0
Form type: 4
Filing time: 30 Nov 2023, 09:08:24 UTC
Previous filing: 26 Oct 2023
Next filing: 26 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYTH	Common Stock	Award	$0	+7,466	+305%	$0.000000	9,915	28 Nov 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee directorcompensation policy. Grant reflects director compensation for the third quarter of 2023. The number of shares received in lieu of cash was calculated based on the closing price of $1.34per share of common stock on November 28, 2023.

Content

Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee directorcompensation policy. Grant reflects director compensation for the third quarter of 2023. The number of shares received in lieu of cash was calculated based on the closing price of $1.34per share of common stock on November 28, 2023.